IP Verse

Atugen Ag opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Dec 2, 2020

Title:

Further Novel Forms Of Interfering Rna Molecules

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP1857547	Dec 2, 2020	Further Novel Forms Of Interfering Rna Molecules	3

ALNYLAM PHARMACEUTICALS, INC.

SANOFI

THE MEDICINES COMPANY UK LIMITED

Feel free to send us a message here and we will get back to you